一种促进炎症解决的干预措施可以防止由左心室功能障碍引起的心房动
Roddy Hiram1, Feng Xiong1,2, Patrice Naud1
1Department of Medicine, Montreal Heart Institute (MHI), Université de Montréal, 5000 Belanger Street, Montreal, Quebec, CanadaH1T 1C8.
Cardiovascular research
|December 13, 2023
概括
在大鼠中,Resolvin-D1 (RvD1) 治疗抑制了心房重塑,并在心肌梗塞 (MI) 后降低了心房动的脆弱性. 早期的RvD1保护了心室,而晚期的RvD1则专门针对心房变化,突出了其在AF预防方面的潜力.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 炎症研究 炎症研究
背景情况:
- 炎症在心房动 (AF) 的发展中起着关键作用.
- 溶解素是促进炎症解消的生物活性调解剂.
- 心房失常性重塑与心肌梗塞 (MI) 后的左心室 (LV) 功能障碍有关.
研究的目的:
- 在大鼠模型中,研究resolvin-D1 (RvD1) 对由MI相关的LV功能障碍诱导的心房节律失调性重塑的影响.
- 评估RvD1作为预防或治疗AF基质发展的治疗剂的潜力.
主要方法:
- 通过冠状动脉绑定在老鼠中诱导心肌梗塞 (MI).
- 鼠每天在MI前 (早期RvD1) 或在MI后7天 (晚期RvD1) 接受RvD1的腹腔内注射.
- 电生理学研究,光学映射,马森三色染色和基因表达分析被用来评估AF脆弱性,心房导电,纤维化和相关生物标志物.
主要成果:
- 早期的RvD1显著减少了心脏病发作的大小,并保留了LV喷射分数.
- 早期和晚期的RvD1治疗都抑制了MI诱导的心房纤维化和与炎症相关的基因表达.
- 服用RvD1减弱了心房动脉节律不良的易感性,并改善了心房导电速度后MI.
结论:
- 瑞索尔-D1有效抑制了与心肌梗塞有关的心房失常性心律重塑.
- 早期的RvD1表现出心室和心房的保护作用,而晚期的RvD1则专门针对心房重塑和AF促进.
- 这些发现表明,像RvD1这样的促进炎症解决的化合物是缓解AF发展的有希望的心脏保护剂.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
01:28Inflammatory Response
2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
21
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
21
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
187
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
187
01:22Heart Failure Drugs: β-Blockers
341
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
341
01:22Heart Failure Drugs: Diuretics
395
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
395